Alnylam Canada ULC is pleased to announce that GIVLAARI® (givosiran injection) is now funded across Canada through both public and private insurance plans for patients living with acute hepatic ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Ionis Pharmaceuticals, Inc. for the ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...